{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:30:04Z","timestamp":1792416604307,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.anndiagpath.2022.151908","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T18:20:18Z","timestamp":1643826018000},"page":"151908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Renal cancer associated with Xp11.2 translocation\/TFE3 gene fusion: Clinicopathological analysis of 13 cases"],"prefix":"10.1016","volume":"58","author":[{"given":"Runlin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2022.151908_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4111\/kju.2015.56.3.212","article-title":"Clinicopathological features of Xp11.2 translocation renal cell carcinoma","volume":"56","author":"Lim","year":"2015","journal-title":"Korean J Urol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/modpathol.2013.208","article-title":"Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage","volume":"27","author":"Ellis","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0020","doi-asserted-by":"crossref","first-page":"21677","DOI":"10.1038\/srep21677","article-title":"Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic chinese population","volume":"6","author":"Qu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000146007.54092.37","article-title":"Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR","volume":"29","author":"Argani","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0030","first-page":"133","article-title":"Review of renal carcinoma associated with Xp11.2 translocations\/TFE3 gene fusions with focus on pathobiological aspect","volume":"27","author":"Kuroda","year":"2012","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0035","article-title":"Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/modpathol.2013.83","article-title":"Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases","volume":"27","author":"Hodge","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015793","article-title":"Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization","volume":"5","author":"Hong","year":"2010","journal-title":"PloS one"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0050","article-title":"Renal cell carcinoma associated with Xp11.2 Translocation\/TFE3 gene fusions:clinical features, treatments and prognosis","volume":"11","author":"Liu","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12894-018-0419-3","article-title":"Bilateral Xp11.2 translocation renal cell carcinoma: a case report","volume":"18","author":"Karashima","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12894-016-0154-6","article-title":"Clinical characteristics of XP11.2 translocation\/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies","volume":"16","author":"Cheng","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0065","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion: a rare case report with review of the literature","volume":"2013","author":"Ahluwalia","year":"2013","journal-title":"Case Rep. Urology"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0070","first-page":"83","article-title":"Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: a case report","volume":"8","author":"Pan","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4161\/cbt.24344","article-title":"Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE)","volume":"14","author":"Hirobe","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00795-008-0423-x","article-title":"Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations\/TFE3 gene fusions","volume":"43","author":"Kuroda","year":"2010","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0085","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/cas.14026","article-title":"MicroRNA-204-5p: a novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma","volume":"110","author":"Kurahashi","year":"2019","journal-title":"Cancer Science"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0090","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s12253-019-00792-0","article-title":"Clinicopathological findings on 28 cases with XP11.2 renal cell carcinoma","volume":"26","author":"Kuthi","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0095","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3892\/ol.2016.4211","article-title":"Xp11.2 translocation renal cell carcinoma with multiple bone metastases: a case report","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.anndiagpath.2022.151908_bb0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dc.20523","article-title":"Renal cell carcinoma with an Xp11.2 translocation in a 16-year-old girl: a case report with cytological features","volume":"34","author":"Mansouri","year":"2006","journal-title":"Diagn Cytopathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:49Z","timestamp":1761078829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":20,"alternative-id":["S1092913422000107"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151908","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal cancer associated with Xp11.2 translocation\/TFE3 gene fusion: Clinicopathological analysis of 13 cases","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151908"}}